What is ZYPPAH?
ZYPPAH specializes in developing and marketing advanced anti-snoring devices, most notably its FDA-cleared mouthpiece. This innovative product features a patented tongue strap mechanism designed for superior effectiveness in preventing snoring. Clinically validated to be 91% effective, ZYPPAH's solutions aim to improve sleep quality for individuals and their partners. The company also offers complementary products such as mouth tape, all geared towards promoting healthier sleep. With a strong customer base exceeding 500,000 and a 91-day money-back guarantee, ZYPPAH has established itself as a trusted provider in the sleep wellness market. Their offerings are also approved for Flexible Spending Account (FSA) and Health Savings Account (HSA) reimbursement, further enhancing accessibility.
How much funding has ZYPPAH raised?
ZYPPAH has raised a total of $144K across 1 funding round:
Debt
$144K
Debt (2021): $144K with participation from PPP
Key Investors in ZYPPAH
PPP
Public-Private Partnership
What's next for ZYPPAH?
The recent large-scale, late-stage funding, characterized as a major strategic investment, positions ZYPPAH for accelerated growth and market penetration. This capital infusion is expected to fuel further research and development, enhance manufacturing capabilities, and expand marketing efforts to reach a broader audience struggling with snoring. ZYPPAH's focus on clinically proven efficacy and customer satisfaction, combined with its strategic financial backing, suggests a strong outlook for continued expansion and leadership in the competitive sleep-aid industry. The company is poised to leverage this investment to solidify its position as a key player in improving sleep health globally.
See full ZYPPAH company page
